Intravenous Infusions Limited (IIL.gh) 2019 Abridged Report

first_imgIntravenous Infusions Limited (IIL.gh) listed on the Ghana Stock Exchange under the Pharmaceuticals sector has released it’s 2019 abridged results.For more information about Intravenous Infusions Limited (IIL.gh) reports, abridged reports, interim earnings results and earnings presentations, visit the Intravenous Infusions Limited (IIL.gh) company page on AfricanFinancials.Document: Intravenous Infusions Limited (IIL.gh)  2019 abridged results.Company ProfileIntravenous Infusions Limited (IIL) was incorporated in 1969 and began operations in 1974 as the first pharmaceutical company producing intravenous fluids in Ghana. The main business activity of IIL is the production of intravenous infusions for therapeutic purposes. Intravenous infusion therapy, commonly called IV, refers to the administration of fluids, drugs, or blood directly into the circulatory system through a vein. Intravenous Infusions Limited is listed on the Ghana Stock Exchangelast_img read more